Drug Shortage Report for ERFA-AMIKACIN

Last updated on 2024-11-27 History
Report ID 139653
Drug Identification Number 02489147
Brand name ERFA-AMIKACIN
Common or Proper name ERFA-AMIKACIN
Company Name SEARCHLIGHT PHARMA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) AMIKACIN
Strength(s) 250MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 2ML
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-06-01
Actual start date 2021-05-19
Estimated end date Unknown
Actual end date 2024-11-22
Shortage status Resolved
Updated date 2024-11-27
Company comments Discontinuation
Health Canada comments
Tier 3 Status No
Contact Address 1600 RUE NOTRE DAME OUEST, SUITE 312
MONTREAL, QUEBEC
CANADA H3J 1M1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2024-11-27 English Compare
v6 2021-12-08 French Compare
v5 2021-12-08 English Compare
v4 2021-12-08 English Compare
v3 2021-05-20 English Compare
v2 2021-05-19 French Compare
v1 2021-05-19 English Compare

Showing 1 to 7 of 7